New Heart Ultrasound Research Shows Hope for Diagnosing and Treating Fatal Heart ...( Leading-edge findings reveal...),Health

Leading-edge findings revealed at the American Society of

Echocardiography's Scientific Sessions

TORONTO, June 9 /PRNewswire/ -- The American Society of Echocardiography (ASE) holds its 19th Annual Scientific Sessions June 7-11 at the Metro Toronto Convention Centre in Toronto, Ontario, Canada. The event provides a forum for the world's leading researchers in cardiovascular medicine to present their most-recent findings. This year's presentations include several that will have significant impact on diagnosis and treatment of heart disease and the application of echocardiograms, otherwise called heart ultrasounds.

To view the full text of the press releases and study abstracts, please visit http://www.asecho.org/Media_Public_Info/2008MediaKit.php
FETAL HEART ULTRASOUND DETERMINES PRENATAL MARKERS FOR CONGENITAL HEART

DISEASE Early detection of congenital heart disease in the fetus is often critical to successful treatment. New research revealed at the 19th Annual Scientific Sessions of the American Society of Echocardiography (ASE) indicates fetal heart ultrasound technology can help detect congenital heart anomalies before birth, thereby allowing doctors to plan treatment sooner.

Prenatal ventricular size discrepancy with a disproportionately smaller left ventricle than right ventricle (L-R/VD) in the fetus is a strong marker for various forms of congenital heart disease. The study concluded that fetal parameters expressing the magnitude of L-R/VD can help identify those who will require neonatal intervention. The findings will improve the ability to determine which fetuses are likely to need neonatal intervention and which will not.
STUDY REVEALS BENEFITS OF NON-INVASIVE TECHNOLOGY TO DETECT REJECTIONS OF

TRANSPLANTED HEART Research unv
'/>"/>